Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC
- PMID: 6791738
- PMCID: PMC1506820
- DOI: 10.1136/bmj.283.6294.760
Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC
Similar articles
-
Treatment of patients with factor VIII autoantibodies by staphylococcal protein A-based immunoadsorption and immunosuppression.Br J Haematol. 2001 Sep;114(4):956-8. doi: 10.1046/j.1365-2141.2001.03006-3.x. Br J Haematol. 2001. PMID: 11564094 No abstract available.
-
An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy.Am J Med Sci. 1985 Dec;290(6):246-8. doi: 10.1097/00000441-198512000-00004. Am J Med Sci. 1985. PMID: 3936359
-
Control of life-threatening bleeding by combined plasmapheresis and immunosuppressive treatment in a haemophiliac with inhibitors.Arch Dis Child. 1980 Aug;55(8):641-3. doi: 10.1136/adc.55.8.641. Arch Dis Child. 1980. PMID: 6776907 Free PMC article.
-
[Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].Ther Umsch. 1979 Apr;36(4):326-9. Ther Umsch. 1979. PMID: 377556 Review. German. No abstract available.
-
Immunosuppression of factor VIII inhibitors in nonhemophilic patients.Semin Hematol. 1993 Apr;30(2 Suppl 1):28-31. Semin Hematol. 1993. PMID: 8480194 Review. No abstract available.
Cited by
-
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.Haematologica. 2009 Apr;94(4):566-75. doi: 10.3324/haematol.2008.001743. Haematologica. 2009. PMID: 19336751 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical